Associations of epigenetic age acceleration with motor impairment: Evidence from the Parkinson’s Progression Markers Initiative cohort.
Key claim: Accelerated epigenetic aging is robustly associated with longitudinal progression of tremor-related motor phenotypes in Parkinson’s disease, particularly in men, across multiple epigenetic clocks.
Abstract
Motor decline is a hallmark of Parkinson’s disease (PD) and biological aging, yet the specific relationship between systemic biological aging and neuromotor function remains under-characterized. This study leveraged longitudinal phenotypic and whole-blood DNA methylation data from the Parkinson’s Progression Markers Initiative (PPMI) to evaluate associations between seven epigenetic aging measures, spanning first-generation, second-generation (risk-optimized), rate-based, and next-generation deep-learning clocks, and motor impairment. Motor function was assessed using the Movement Disorder Society-sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). While cross-sectional analyses yielded limited evidence, longitudinal repeated-measures analyses revealed robust associations between accelerated epigenetic aging and worsening postural and kinetic tremor phenotypes. Associations with gait, rigidity, and bradykinesia were largely non-significant or inversely related in the overall sample. Sex-stratified analyses revealed sexual dimorphism, with males exhibiting a broad, multi-clock phenotype (involving Horvath, PhenoAge, and GrimAge), where accelerated aging was associated with worsening tremor, gait, and rigidity. In contrast, females showed restricted associations, primarily linking the Hannum clock to tremor and global staging. These findings suggest that systemic biological aging is more strongly associated with longitudinal progression of tremor-related phenotypes than with rigidity or bradykinesia, although mechanistic interpretations regarding specific neural circuits remain hypothesis-generating. Accordingly, accelerated epigenetic aging is robustly associated with longitudinal tremor progression in this cohort, particularly in men, suggesting these metrics may serve as valuable biomarkers for monitoring progression and risk stratification in tremor-dominant phenotypes.
Why this matters
Most epigenetic-clock associations to date have anchored on mortality, cancer, or general cognitive decline; a phenotype-specific link to tremor progression in PD, with a clear male-skewed signal, sharpens the clocks’ claim to track domain-relevant neurodegenerative trajectories rather than only global biological age. It also flags sex as a non-trivial moderator of clock-phenotype coupling, which matters for how methylation readouts are deployed as trial endpoints in neurodegeneration.